Eton Pharmaceuticals (ETON) Raw Materials (2024 - 2025)
Eton Pharmaceuticals' (ETON) quarterly Raw Materials came in at $557000.0 in Q4 2025, down 89.6% year-on-year from $5.4 million in Q4 2024, and down 89.6% quarter-over-quarter from $5.4 million in Q4 2024.
Eton Pharmaceuticals (ETON) Raw Materials (2024 - 2025) Analysis & Trends
Eton Pharmaceuticals has disclosed Raw Materials across 2 years of filings, most recently posting $557000.0 for Q4 2025.
- Raw Materials for Q4 2025 came in at $557000.0, down 89.6% year-over-year; the trailing twelve-month figure through Dec 2025 was $557000.0 (down 89.6% YoY), and the FY2025 annual result was $557000.0, down 89.6% from the prior year.
- Raw Materials came in at $557000.0 for Q4 2025 at Eton Pharmaceuticals, down from $5.4 million in the prior quarter.
- In the past five years, Raw Materials ranged from a high of $5.4 million in Q4 2024 to a low of $557000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Eton Pharmaceuticals | 806.97 Mn | 781.03 Mn | 13.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 557,000.00 |
| Dec 31, 2024 | 5.36 Mn |